Bio-Techne Corp (TECH) is a leading biotechnology company that specializes in the development and manufacturing of innovative life science tools and reagents. As a leader in the industry, Bio-Techne Corp has a strong focus on research and development, allowing them to stay at the forefront of technological advancements in the field. Technical analysis plays a crucial role in helping investors make informed decisions about their investments in Bio-Techne Corp.

One of the key technical indicators for analyzing Bio-Techne Corp stock is the Relative Strength Index (RSI). The RSI is a momentum oscillator that measures the speed and change of price movements. By analyzing the RSI, investors can determine whether the stock is overbought or oversold, which can help guide their buying or selling decisions.

Bio-Techne (TECH) Technical Analysis

Learn about the technical indicators of Bio-Techne Corp (TECH) stock, including RSI, ADX, MACD, ROC, STOCHRSI, and WILLR. Explore the company's technical analysis rating and make informed investment decisions.

Bio-Techne Corp (TECH) Technical Analysis: Indicators and Ratings

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It has strategic partnership with Lunaphore Technologies S.A. to develop automated same-slide spatial multiomics solution. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

Bio-Techne

NASDAQ

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	36.06	Neutral	28.4%
auto_graphMACD	-2.98	Neutral	50.5%
auto_graphCCI	-226.73	Buy	142.3%
auto_graphADX	19.05	Neutral	-
auto_graphATR	25.30	Buy	-
auto_graphWILLR	-86.18	Buy	70.0%
auto_graphROC	-30.57	Neutral	36.7%
auto_graphSTOCHRSI	0.00	Buy	219.0%

Buy	4	-50.00%
Hold	4	-50.00%
Sell	0	-100.00%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

Bio-Techne (TECH) Technical Analysis

Keep an eye on Bio-Techne

Frequently Asked Questions

What are the technical signals for Bio-Techne (TECH) stock based on the last 30 days?

Take Your Investments to a Whole New Level